Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

NCT04216550 · clinicaltrials.gov ↗

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioma

Interventions

DRUG: Apatinib

Sponsor

The First Affiliated Hospital of Zhengzhou University